A study of multinucleated giant cells in esophageal cancer.

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Hui WangJiang Gu

Abstract

To evaluate the occurrence, abundance, distribution, nature and clinical significance of multinucleated giant cell (MGC) in esophageal cancer. MGCs were examined with conventional pathology, immunohistochemistry and immunofluorescence in 107 esophageal cancer tissues. The findings were correlated to pathological diagnosis and clinical behavior of the cancers. MGCs were identified in 31.7% (34/107) of the cases. MGCs were positive for CD11c, CD11b, CD32, CD16, HLA-DR and MMP9, and negative for CD163, CD206 and CD64 giving a molecular profile of proinflammatory M1 but not immunosuppressive M2. MGCs were significantly related to decreased lymph node metastasis (p = 0.011), low pTNM stage (p = 0.044), favorable survival (p = 0.04), squamous cell cancer type rather than other histopathological subtypes (p = 0.020) and associated to better differentiation (p = 0.063). MGCs belong to M1 macrophage and perform phagocytosis and scavenging of cancer cells that would benefit patients' survival and could serve as a prognostic marker.

References

Jan 1, 1986·Head & Neck Surgery·D OphirG Marshak
May 1, 1993·British Journal of Cancer·B DaviesF R Balkwill
Jul 25, 2000·Postgraduate Medical Journal·D G James
Feb 24, 2001·Current Problems in Cancer·R Wong, R Malthaner
Mar 13, 2001·Annual Review of Immunology·J V Ravetch, S Bolland
May 12, 2001·Pathology Oncology Research : POR·A John, G Tuszynski
May 15, 2002·Immunology Letters·Roy Jefferis, John Lund
Aug 8, 2002·Journal of the National Cancer Institute·Suyun HuangIsaiah J Fidler
Apr 3, 2003·Journal of Dermatological Science·Hiroyuki OkamotoTakeshi Horio
Jun 21, 2003·Acta Dermato-venereologica·Hiroyuki OkamotoTakeshi Horio
Oct 1, 1962·American Journal of Surgery·H B GREGORIEM P MOORE
Jan 7, 2004·Nature Reviews. Cancer·Jeffrey W Pollard
Nov 9, 2004·Trends in Immunology·Alberto MantovaniMassimo Locati
Mar 8, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Antonio SicaPaola Allavena
Dec 17, 2008·Clinical and Experimental Immunology·T C M Th van MaarsseveenP J van Diest
Sep 11, 2009·Journal of Leukocyte Biology·G SolinasP Allavena
Feb 6, 2010·Science·Frederic GeissmannKlaus Ley
Jun 1, 2010·Immunity·Siamon Gordon, Fernando O Martinez
Sep 22, 2010·Nature Immunology·Subhra K Biswas, Alberto Mantovani
Dec 20, 2011·Journal of Translational Medicine·Moniek Heusinkveld, Sjoerd H van der Burg
Oct 16, 2012·The American Journal of Pathology·Laurie A Shuman MossWilliam G Stetler-Stevenson
Oct 26, 2012·The Journal of Pathology·Alberto MantovaniMassimo Locati
Jan 22, 2014·Nature Reviews. Immunology·Martin GuilliamsBart N Lambrecht
Feb 7, 2014·Annual Review of Immunology·V Michael Holers
Apr 11, 2015·Cancer Cell·Brian Ruffell, Lisa M Coussens
Dec 22, 2015·Immunobiology·Srinivas MamidiMichael Kirschfink
Sep 14, 2016·The Annals of Thoracic Surgery·Sahar A SaddoughiMark S Allen
Sep 21, 2016·Journal of Clinical Pathology·Rucha S DagaonkarAkash Verma
Oct 19, 2016·The Journal of Pathology·Yoshihiro Komohara, Motohiro Takeya
May 26, 2017·Expert Opinion on Pharmacotherapy·Elfriede BollschweilerArnulf H Hölscher
Sep 19, 2017·Nature Reviews. Immunology·Edimara S ReisJohn D Lambris
Apr 21, 2018·Annual Review of Immunology·Erin E WestClaudia Kemper
Jul 29, 2018·Nature Communications·Tamara MuliaditanJames N Arnold

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.